Recent news on Recombinant Factor Viia

Earnings surge 24% at Denmark's Novo Nordisk  -  May 2, 2007
Pharma Times (subscription),Among the major products in Novo's biopharmaceuticals business, sales of which also climbed 10% to 2.68 billion kroner, NovoSeven (recombinant Factor VIIa)

Neose Announces Two Abstracts on GlycoPEGylated Factor VIIa ...  -  Apr 20, 2007
PharmaLive.com (press release),...relating to GlycoPEGylated recombinant Factor VIIa have been accepted for poster presentations at the XXIst Congress of the International Society on

Novo Nordisk drops NovoSeven for brain haemorrhage  -  Feb 26, 2007
Pharma Times (subscription),Novo will not apply for regulatory approval for NovoSeven (recombinant Factor VIIa) to treat intracerebral haemorrhage (ICH), after mortality and severe

Use of Recombinant Factor VIIa for Hip Surgery in a Patient with ...  -  Feb 1, 2007
Journal of Bone and Joint Surgery (subscription)Recombinant activated factor VII (recombinant factor VIIa) (NovoSeven; Novo Nordisk, Bagsvaerd, Denmark) was approved by the United States Food and Drug

Solid full-year 2006 results for Denmark's Novo Nordisk  -  Jan 31, 2007
Pharma Times (subscription),Among the major products in Novo's biopharmaceuticals business, sales of which climbed 12% to 10.88 billion kroner, NovoSeven (recombinant Factor VIIa) was

ABC NEWS Medical Unit  -  Dec 5, 2006
ABC NewsRecombinant Factor VIIa — or rF7a, sold as NovoSeven — is a blood-clotting medication approved by the FDA only to control bleeding episodes in some

Dealing with uncontrolled bleeding  -  Nov 29, 2006
Hindu,That drug is NovoSeven (Recombinant Factor VIIa or rFVIIa), made by Nodo Norvisk, the Danish parmaceuticals company. It has only been licensed foruse with

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional